(Q34364901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Are atypical antipsychotic drugs also atypical antidepressants? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

G Malhi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand Journal of Psychiatry

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

631-638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

Psychotic (delusional) depression: a meta-analysis of physical treatments

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Hypomania-like syndrome induced by olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Chronic mild stress-induced anhedonia: a realistic animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Antidepressant-like effects of dopamine agonists in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Muscarinic m4 receptor activation by some atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

A novel augmentation strategy for treating resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Major tranquillisers used as antidepressants. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

IBZM-SPECT imaging of dopamine D2 receptors with typical and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0004867010060512

21 January 2018

Identifiers

DOI

10.1080/0004867010060512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551279%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference